Skip to content
Riskpilot
← Back to search
Sign in
Get full access
CMC Drug Product Consulting ApS
APS
Active
CVR 38817566
Sønderkær 29, 2650
Hvidovre
Engineering activities and related technical consultancy
· NACE 7112
Est. 2017
3 employees
www.cmcdp.dk
Watchlist
Share
Denmark
/
Companies
/
Engineering activities and related technical consultancy
/
CMC Drug Product Consulting ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
1M
2M
3M
3M
3M
2021
2M
2022
1M
2023
1M
2024
1M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
1M
2021
0M
2022
-1M
2023
0M
2024
0M
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
2.739
1.544
501
1.493
1.440
Staff expenses
-1.881
-1.391
-1.350
-1.346
-1.375
EBITDA
858
152
-849
148
64
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
858
152
-849
148
64
Net financials
33
30
-2
-40
-1
Profit before tax
891
182
-851
108
63
Tax
199
47
-184
26
15
Net profit
692
136
-667
82
49
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
1.678
608
282
836
913
Equity
1.329
472
-463
-381
692
Long-term debt
0
0
0
0
0
Short-term debt
348
136
744
1.216
221
Total debt
348
136
744
1.216
221
Financial ratios
5-year trend
EBITDA margin
4.5%
This company
15.8%
Market median
-72% vs market
2021
2025
Equity ratio
75.8%
This company
38.2%
Market median
+98% vs market
2021
2025
Return on equity
7.0%
This company
18.4%
Market median
-62% vs market
2021
2025
Net profit margin
3.4%
This company
8.1%
Market median
-58% vs market
2021
2025
Asset turnover
1.58×
This company
1.12×
Market median
+41% vs market
2021
2025
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on CMC Drug Product Consulting ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
